nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Balancing neurotrophin pathway and sortilin function: Its role in human disease
|
Al-Yozbaki, Minnatallah |
|
|
1874 |
2 |
p. |
artikel |
2 |
Biophysical signal transduction in cancer cells: Understanding its role in cancer pathogenesis and treatment
|
Huang, XiaoLei |
|
|
1874 |
2 |
p. |
artikel |
3 |
Cancer associated fibroblast mediated chemoresistance: A paradigm shift in understanding the mechanism of tumor progression
|
Jena, Bikash Chandra |
|
|
1874 |
2 |
p. |
artikel |
4 |
Cancer-associated fibroblasts in therapeutic resistance of pancreatic cancer: Present situation, predicaments, and perspectives
|
Han, Xuan |
|
|
1874 |
2 |
p. |
artikel |
5 |
Cancer regeneration: Polyploid cells are the key drivers of tumor progression
|
Moein, Shiva |
|
|
1874 |
2 |
p. |
artikel |
6 |
Choosing tumor mutational burden wisely for immunotherapy: A hard road to explore
|
Li, Rui |
|
|
1874 |
2 |
p. |
artikel |
7 |
COVID-19 and cancer: A guide with suggested COVID-19 rule-out criteria to support clinical decision-making
|
Larson, Christopher |
|
|
1874 |
2 |
p. |
artikel |
8 |
Drug tolerance to target therapy in melanoma revealed at single cell level: What next?
|
Liguoro, Domenico |
|
|
1874 |
2 |
p. |
artikel |
9 |
Editorial Board
|
|
|
|
1874 |
2 |
p. |
artikel |
10 |
EpCAM cellular functions in adhesion and migration, and potential impact on invasion: A critical review
|
Fagotto, François |
|
|
1874 |
2 |
p. |
artikel |
11 |
Exosomes as Biomarkers of Human and Feline Mammary Tumours; A Comparative Medicine Approach to Unravelling the Aggressiveness of TNBC
|
Howard, Jane |
|
|
1874 |
2 |
p. |
artikel |
12 |
Exosomes: The protagonists in the tale of colorectal cancer?
|
Nabariya, Deepti Kailash |
|
|
1874 |
2 |
p. |
artikel |
13 |
Extracellular proteolysis in glioblastoma progression and therapeutics
|
Quesnel, Agathe |
|
|
1874 |
2 |
p. |
artikel |
14 |
Hepatocyte growth factor/MET and CD44 in colorectal cancer: partners in tumorigenesis and therapy resistance
|
Joosten, Sander P.J. |
|
|
1874 |
2 |
p. |
artikel |
15 |
HOX genes and the NF-κB pathway: A convergence of developmental biology, inflammation and cancer biology
|
Pai, Priya |
|
|
1874 |
2 |
p. |
artikel |
16 |
Human MYC G-quadruplex: From discovery to a cancer therapeutic target
|
Wang, Wenmeng |
|
|
1874 |
2 |
p. |
artikel |
17 |
Immunotherapy efficacy on mismatch repair-deficient colorectal cancer: From bench to bedside
|
Lizardo, Darleny Y. |
|
|
1874 |
2 |
p. |
artikel |
18 |
Immunotherapy for advanced hepatocellular carcinoma, where are we?
|
Zhang, Li |
|
|
1874 |
2 |
p. |
artikel |
19 |
Latest perspectives on glucocorticoid-induced apoptosis and resistance in lymphoid malignancies
|
Clarisse, Dorien |
|
|
1874 |
2 |
p. |
artikel |
20 |
LOXL2 in cancer: regulation, downstream effectors and novel roles
|
Wen, Bing |
|
|
1874 |
2 |
p. |
artikel |
21 |
MCM family in gastrointestinal cancer and other malignancies: From functional characterization to clinical implication
|
Wang, Yifei |
|
|
1874 |
2 |
p. |
artikel |
22 |
Mechanically stressed cancer microenvironment: Role in pancreatic cancer progression
|
Hadden, Matthew |
|
|
1874 |
2 |
p. |
artikel |
23 |
Metabolic heterogeneity in cancer: An overview and therapeutic implications
|
Tong, Yu |
|
|
1874 |
2 |
p. |
artikel |
24 |
MYBL2 amplification in breast cancer: Molecular mechanisms and therapeutic potential
|
Bayley, Rachel |
|
|
1874 |
2 |
p. |
artikel |
25 |
Nerve input to tumours: Pathophysiological consequences of a dynamic relationship
|
Hutchings, Charlotte |
|
|
1874 |
2 |
p. |
artikel |
26 |
New insights into affinity proteins for HER2-targeted therapy: Beyond trastuzumab
|
Akbari, Vajihe |
|
|
1874 |
2 |
p. |
artikel |
27 |
Oncometabolites lactate and succinate drive pro-angiogenic macrophage response in tumors
|
Kes, Marjolein M.G. |
|
|
1874 |
2 |
p. |
artikel |
28 |
Pharmacological significance of the non-canonical NF-κB pathway in tumorigenesis
|
Morgan, Dhakshayini |
|
|
1874 |
2 |
p. |
artikel |
29 |
P53 in skin cancer: From a master player to a privileged target for prevention and therapy
|
Loureiro, J.B. |
|
|
1874 |
2 |
p. |
artikel |
30 |
Potential diagnostic and therapeutic roles of exosomes in pancreatic cancer
|
Zhao, Xiangxuan |
|
|
1874 |
2 |
p. |
artikel |
31 |
Power of two: combination of therapeutic approaches involving glucose transporter (GLUT) inhibitors to combat cancer
|
Tilekar, Kalpana |
|
|
1874 |
2 |
p. |
artikel |
32 |
Progress and challenge in development of biotherapeutics targeting MET receptor for treatment of advanced cancer
|
Yao, Hang-Ping |
|
|
1874 |
2 |
p. |
artikel |
33 |
Protein glycosylation in head and neck cancers: From diagnosis to treatment
|
Rasheduzzaman, Mohammad |
|
|
1874 |
2 |
p. |
artikel |
34 |
Protein phosphatase 1 in tumorigenesis: is it worth a closer look?
|
Felgueiras, Juliana |
|
|
1874 |
2 |
p. |
artikel |
35 |
PTEN in osteosarcoma: Recent advances and the therapeutic potential
|
Zheng, Chuanxi |
|
|
1874 |
2 |
p. |
artikel |
36 |
Resistin: An inflammatory cytokine with multi-faceted roles in cancer
|
Sudan, Sarabjeet Kour |
|
|
1874 |
2 |
p. |
artikel |
37 |
Role of tyrosine phosphorylation in modulating cancer cell metabolism
|
Taddei, Maria Letizia |
|
|
1874 |
2 |
p. |
artikel |
38 |
Senescence and castration resistance in prostate cancer: A review of experimental evidence and clinical implications
|
Carpenter, Valerie J. |
|
|
1874 |
2 |
p. |
artikel |
39 |
SOS GEFs in health and disease
|
Baltanás, Fernando C. |
|
|
1874 |
2 |
p. |
artikel |
40 |
Targeting protein tyrosine kinase 6 in cancer
|
Gilic, Milica B. |
|
|
1874 |
2 |
p. |
artikel |
41 |
Targeting tumor-associated macrophages for cancer immunotherapy
|
Shu, Yongheng |
|
|
1874 |
2 |
p. |
artikel |
42 |
The biology and engineered modeling strategies of cancer-nerve crosstalk
|
Gregory, Emory |
|
|
1874 |
2 |
p. |
artikel |
43 |
The emerging role of miRNA clusters in breast cancer progression
|
Kandettu, Amoolya |
|
|
1874 |
2 |
p. |
artikel |
44 |
The implication of long non-coding RNAs in the diagnosis, pathogenesis and drug resistance of pancreatic ductal adenocarcinoma and their possible therapeutic potential
|
Pandya, Gouri |
|
|
1874 |
2 |
p. |
artikel |
45 |
The outstanding antitumor capacity of CD4+ T helper lymphocytes
|
Li, Tong |
|
|
1874 |
2 |
p. |
artikel |
46 |
The PP2A subunit PR130 is a key regulator of cell development and oncogenic transformation
|
Dzulko, Melanie |
|
|
1874 |
2 |
p. |
artikel |
47 |
The use of minimally invasive biomarkers for the diagnosis and prognosis of hepatocellular carcinoma
|
Trevisan França de Lima, Lucas |
|
|
1874 |
2 |
p. |
artikel |
48 |
The ZAR1 protein in cancer; from epigenetic silencing to functional characterisation and epigenetic therapy of tumour suppressors
|
Deutschmeyer, Verena E. |
|
|
1874 |
2 |
p. |
artikel |
49 |
Unmasking carcinoma-associated fibroblasts: Key transformation player within the tumor microenvironment
|
Meng, Qing |
|
|
1874 |
2 |
p. |
artikel |